Crinetics Pharmaceuticals (CRNX) Stock: Buy, Sell, or Hold?
$84.95
+0.11 (+0.13%)
â˛
5d:
+0.2%
30d:
+1.71%
90d:
+146.09%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (64%)
Quality Score
46/100
Position
FAIR
Forward P/E & Valuation
-21.0x
Next 12M consensus est.
Wall Street Target
$85.50
+0.6% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$84.67 / $85.01
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: CRNX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When CRNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CRNX is currently trading at $84.95, which is considered fair based on recent price action.
Technical Outlook: Technically, CRNX is in a strong uptrend. The price is currently testing key support at $84.67. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRNX is in a strong uptrend. The price is currently testing key support at $84.67. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
46/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
Trading Range & Key Levels
Support Level
$84.67
Resistance Level
$85.01
Current Trend
Strong Uptrend
Technical data as of
Aug 31, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (44/100)
- NEUTRAL: Near Wall St target ($85.50)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-21.00
Wall Street Target
$85.50
(+0.6%)
Revenue Growth (YoY)
2336.3%
Share CRNX Analysis
Share this live CRNX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CRNX)
Bullish
3 Retail Mentions
Reddit / WSB Comments
2
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 16, 2026
Daily AI digest
AI Retail Discussion Summary:
Vertex Pharmaceuticals (VRTX) announced an agreement to acquire Crinetics Pharmaceuticals (CRNX) for $85 per share in cash, valuing the deal at around $10 billion.
Key Retail Themes:
M&A activity in the pharmaceutical industry
Vertex's expansion into new therapeutic areas
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 9:22 AM ET
Data refreshes hourly during market hours. Next update: 10:22 AM
Data refreshes hourly during market hours. Next update: 10:22 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals IâĻ |
STRONG BUY
32 analysts |
$592 | 44 HOLD |
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$302 | 55 HOLD |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 35 SELL |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
15 analysts |
$22 | 67 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$75 | 66 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CRNX Research Pages
